Your Article Summary
See Latest Articles“Prepandemic” Immunization for Novel Influenza Viruses, “Swine Flu” Vaccine, Guillain-Barre Syndrome, and the Detection of Rare Severe Adverse Events
The Journal of Infectious Diseases, 07/02/09
Evans D et al. - This case study is especially timely, given the recent spread of a novel influenza A(H1N1) virus in humans in Mexico and beyond. Following this, the authors examine available safety data from clinical trials of H5N1 vaccines and briefly discuss how vaccine safety could be monitored in a postmarketing surveillance setting.
Related Articles
Medical Schools Make Plans to Address Swine Flu
AAMC Reporter, 11/03/09
Relevance Score: 70%
Cholesterol drugs may improve flu survival
The Seattle Times, 10/30/09
Relevance Score: 66%
Initial psychological responses to Influenza A, H1N1 (Swine flu)
BMC Infectious Diseases, 10/07/09
Relevance Score: 66%
Asthma and Swine Flu: What You Need to Know
U.S. News & World Report, 10/19/09
Relevance Score: 65%
EMEA recommends authorization of swine flu vaccines
Pharmaceutical Technology, 10/14/09
Relevance Score: 65%
Today in Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
The Effects of Influenza A Virus PB1-F2 Protein on Polymerase Activity Are Strain Specific and Do Not Impact Pathogenesis
Journal of Virology, 12/16/09
Role of Scavenger Receptor Class B Type I in Hepatitis C Virus Entry: Kinetics and Molecular Determinants
Journal of Virology, 12/16/09
Role of Nuclear Factor Y in Stress-Induced Activation of the Herpes Simplex Virus Type 1 ICP0 Promoter
Journal of Virology, 12/16/09